Microbial engineering for shikimate biosynthesis

Enzyme Microb Technol. 2023 Oct:170:110306. doi: 10.1016/j.enzmictec.2023.110306. Epub 2023 Aug 15.

Abstract

Shikimate, a precursor to the antiviral drug oseltamivir (Tamiflu®), can influence aromatic metabolites and finds extensive use in antimicrobial, antitumor, and cardiovascular applications. Consequently, various strategies have been developed for chemical synthesis and plant extraction to enhance shikimate biosynthesis, potentially impacting environmental conditions, economic sustainability, and separation and purification processes. Microbial engineering has been developed as an environmentally friendly approach for shikimate biosynthesis. In this review, we provide a comprehensive summary of microbial strategies for shikimate biosynthesis. These strategies primarily include chassis construction, biochemical optimization, pathway remodelling, and global regulation. Furthermore, we discuss future perspectives on shikimate biosynthesis and emphasize the importance of utilizing advanced metabolic engineering tools to regulate microbial networks for constructing robust microbial cell factories.

Keywords: Biochemical strategy; Chassis construction; Global regulation; Pathway remold; Shikimate biosynthesis.

Publication types

  • Review

MeSH terms

  • Antiviral Agents*
  • Metabolic Engineering*
  • Microbial Consortia
  • Oseltamivir

Substances

  • shikimate
  • Antiviral Agents
  • Oseltamivir